A oneyear, open label outpatient, parallel group trial assessing the impact of the availability of inhaled insulin (Exubera) on glycemic control in patients with T2DM who are poorly controlled an a minimum of two oral diabetic agents / Riccardi, Gabriele. - (2007).
A oneyear, open label outpatient, parallel group trial assessing the impact of the availability of inhaled insulin (Exubera) on glycemic control in patients with T2DM who are poorly controlled an a minimum of two oral diabetic agents
RICCARDI, GABRIELE
2007
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
